MIH
ZBH icon

Meitav Investment House’s Zimmer Biomet ZBH Stock Holding History

Meitav Investment House’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,257
Closed -$227K – 419
2018
Q4 		$227K Hold
2,257
– – 0.01% 298
2018
Q3 		$285K Hold
2,257
– – 0.01% 397
2018
Q2 		$244K Sell
2,257
-5,016
-69% -$546K 0.01% 396
2018
Q1 		$770K Buy
+7,273
New +$845K 0.04% 226

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Meitav Investment House's ZBH Position: Q1 2019 in Review

Meitav Investment House sold out of Zimmer Biomet (ZBH) in Q1 2019, closing a stake of 2,257 shares — an estimated $227K sold.

Meitav Investment House first reported a position in ZBH in Q1 2018 and held it in 4 quarters. The position peaked at $770K in Q1 2018. 896 funds tracked by Wall St. Rank hold ZBH as of Q1 2019.

  • Meitav Investment House reported no remaining Zimmer Biomet position as of Q1 2019 after selling out during the quarter.
  • Meitav Investment House sold 2,257 Zimmer Biomet shares in Q1 2019, an estimated $227K.
  • Meitav Investment House first reported a position in Zimmer Biomet in Q1 2018 and held it in 4 quarters.
  • Meitav Investment House's Zimmer Biomet position peaked at $770K in Q1 2018.
  • 896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2019.

Based on Meitav Investment House's 13F filing for Q1 2019, filed 13 May 2019.